Several studies have demonstrated that nonsteroidal anti-inflammatory drugs, such as acetylsalicylic acid (ASA), can have inhibitory or enhancing effects on inflammatory cell function. These effects seem independent of cyclooxygenase activity and prostaglandin synthesis inhibition. Here, we examined the effect of ASA on bone marrow-derived mast cells in more detail. ASA blocked the expression of cyclooxygenase-2, the production of tumor necrosis factor-a and interleukin-6, and the release of granule mediators from mast cells in a concentration-dependent fashion. Concomitantly, ASA inhibited nuclear factor (NF)-kB activity, as well as the phosphorylation and breakdown of the inhibitory protein IkB-a. We thus propose that the anti-inflammatory effects of ASA in mast cells are due to suppression of IkB kinase activity, thereby inhibiting subsequent phosphorylation and degradation of IkB-a, activation of NF-kB, and transcription of proinflammatory cytokines. The inhibition of BMMC degranulation was independent of NF-kB activation, however. Interestingly, the expression of cyclooxygenase-2 was not inhibited at 1 mM ASA, but was even enhanced significantly. The latter might contribute to the adverse effects of ASA in ASA-sensitive asthmatics. #